Substituted piperazinyl pyrazines and pyridines as 5-HT

Substituted piperazinyl pyrazines and pyridines as 5-HT

7 The present invention provides selective 5-HTreceptor antagonist compounds of Formula I and their use in the treatment of migraine:

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cohen, Michael Philip, Hellman, Sarah Lynne, Hollinshead, Sean Patrick, Filla, Sandra Ann, Tidwell, Michael Wade
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Cohen, Michael Philip
Hellman, Sarah Lynne
Hollinshead, Sean Patrick
Filla, Sandra Ann
Tidwell, Michael Wade
description 7 The present invention provides selective 5-HTreceptor antagonist compounds of Formula I and their use in the treatment of migraine:
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08048884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08048884</sourcerecordid><originalsourceid>FETCH-uspatents_grants_080488843</originalsourceid><addsrcrecordid>eNrjZDAPLk0qLsksKS1JTVEoyCxILUqsysyrzFEoqASzUosVEvNSQLzMFAivWMFU1yOEh4E1LTGnOJUXSnMzKLi5hjh76JYWFySWpOaVFMenFyWCKAMLAxMLCwsTYyKUAADLPC70</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted piperazinyl pyrazines and pyridines as 5-HT</title><source>USPTO Issued Patents</source><creator>Cohen, Michael Philip ; Hellman, Sarah Lynne ; Hollinshead, Sean Patrick ; Filla, Sandra Ann ; Tidwell, Michael Wade</creator><creatorcontrib>Cohen, Michael Philip ; Hellman, Sarah Lynne ; Hollinshead, Sean Patrick ; Filla, Sandra Ann ; Tidwell, Michael Wade ; Eli Lilly and Company</creatorcontrib><description>7 The present invention provides selective 5-HTreceptor antagonist compounds of Formula I and their use in the treatment of migraine:</description><language>eng</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8048884$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8048884$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Cohen, Michael Philip</creatorcontrib><creatorcontrib>Hellman, Sarah Lynne</creatorcontrib><creatorcontrib>Hollinshead, Sean Patrick</creatorcontrib><creatorcontrib>Filla, Sandra Ann</creatorcontrib><creatorcontrib>Tidwell, Michael Wade</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>Substituted piperazinyl pyrazines and pyridines as 5-HT</title><description>7 The present invention provides selective 5-HTreceptor antagonist compounds of Formula I and their use in the treatment of migraine:</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDAPLk0qLsksKS1JTVEoyCxILUqsysyrzFEoqASzUosVEvNSQLzMFAivWMFU1yOEh4E1LTGnOJUXSnMzKLi5hjh76JYWFySWpOaVFMenFyWCKAMLAxMLCwsTYyKUAADLPC70</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Cohen, Michael Philip</creator><creator>Hellman, Sarah Lynne</creator><creator>Hollinshead, Sean Patrick</creator><creator>Filla, Sandra Ann</creator><creator>Tidwell, Michael Wade</creator><scope>EFH</scope></search><sort><creationdate>20111101</creationdate><title>Substituted piperazinyl pyrazines and pyridines as 5-HT</title><author>Cohen, Michael Philip ; Hellman, Sarah Lynne ; Hollinshead, Sean Patrick ; Filla, Sandra Ann ; Tidwell, Michael Wade</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_080488843</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Cohen, Michael Philip</creatorcontrib><creatorcontrib>Hellman, Sarah Lynne</creatorcontrib><creatorcontrib>Hollinshead, Sean Patrick</creatorcontrib><creatorcontrib>Filla, Sandra Ann</creatorcontrib><creatorcontrib>Tidwell, Michael Wade</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Cohen, Michael Philip</au><au>Hellman, Sarah Lynne</au><au>Hollinshead, Sean Patrick</au><au>Filla, Sandra Ann</au><au>Tidwell, Michael Wade</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted piperazinyl pyrazines and pyridines as 5-HT</title><date>2011-11-01</date><risdate>2011</risdate><abstract>7 The present invention provides selective 5-HTreceptor antagonist compounds of Formula I and their use in the treatment of migraine:</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08048884
source USPTO Issued Patents
title Substituted piperazinyl pyrazines and pyridines as 5-HT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T13%3A54%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Cohen,%20Michael%20Philip&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2011-11-01&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08048884%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true